Form 4 for GEHC GE HealthCare
Accepted 2026-05-01 11:38:55 ET · period of report 2026-05-01 · accession 0001593636-26-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-01 11:38 | 2026-05-01 | GEHC | SACCARO JAMES | CFO | P - Purchase | $60.60 | +3,310 | 87.5K | +4% | +$200.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.01 per share | 2026-05-01 | P | A | 3,310 | $60.60 | 87,471 | D | — | — | (F1) The price reported represents the weighted average price of shares purchased. These shares were purchased in multiple transactions at prices ranging from $60.59 to $60.60, inclusive. The Reporting Person undertakes to provide to GE HealthCare Technologies Inc. ("GE HealthCare"), any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. |